GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 23 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $634,000 | +10.3% | 184,927 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $575,000 | -20.7% | 184,927 | -10.0% | 0.00% | -33.3% |
| Q3 2020 | $725,000 | -29.7% | 205,375 | -4.7% | 0.00% | -40.0% |
| Q2 2020 | $1,031,000 | +38.2% | 215,594 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $746,000 | -40.1% | 215,594 | 0.0% | 0.01% | -28.6% |
| Q4 2019 | $1,246,000 | +20.9% | 215,594 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $1,031,000 | -35.0% | 215,594 | 0.0% | 0.01% | -36.4% |
| Q2 2019 | $1,585,000 | -10.0% | 215,594 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $1,761,000 | +19.6% | 215,594 | 0.0% | 0.01% | -8.3% |
| Q4 2018 | $1,473,000 | -66.5% | 215,594 | -33.5% | 0.01% | -58.6% |
| Q3 2018 | $4,401,000 | -41.9% | 324,094 | -49.1% | 0.03% | -49.1% |
| Q2 2018 | $7,570,000 | – | 636,140 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |